Thang Vo-Ta is currently a Translational Health Sciences Programme Alumni at the University of Oxford, where he is furthering his expertise in clinical trials and biotechnology. As the CEO and Co-Founder of Calla Lily Clinical Care, based in London, he leads the development of Callavid, a patented delivery platform for vaginally-delivered drugs, addressing critical needs in womens health, particul...